Olopatadin Orifarm (Olopatadine)

Olopatadine, the active ingredient in Olopatadin Orifarm, is a antihistamine presented as a tablet for oral use. It treats allergic conjunctivitis and other ocular allergy symptoms in adults and children. GNH USA supplies Olopatadin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olopatadin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olopatadine is indicated for allergic eye conditions that involve histamine‑mediated inflammation.

- Allergic conjunctivitis: Reduces redness, itching and swelling of the eyes. - Seasonal allergic rhinoconjunctivitis: Alleviates combined nasal and ocular allergy symptoms. - Vernal keratoconjunctivitis: Helps control chronic inflammation of the cornea and conjunctiva. - Atopic keratoconjunctivitis: Provides relief for persistent ocular itching and discomfort. - Contact lens‑related allergy: Decreases irritation for lens wearers with allergic responses.

Olopatadine is generally well‑tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Burning sensation in the eye - Blurred vision - Headache - Dry eye - Mild ocular irritation - Unpleasant taste (if oral formulation)

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Significant eye pain or vision loss - Persistent swelling of the eyelids - Corneal ulceration - Stevens‑Johnson syndrome - Acute angle‑closure glaucoma

When using Olopatadin Orifarm, consider the following safety measures:

- Assess allergy history: Verify patient has no known hypersensitivity to olopatadine or similar antihistamines. - Monitor ocular health: Regular eye examinations are recommended during prolonged use. - Caution in glaucoma patients: Use with care in individuals with narrow‑angle glaucoma. - Pregnancy and lactation: Discuss risks and benefits with a healthcare professional before use. - Drug interactions: Review concomitant medications for potential additive antihistamine effects. - Store at ambient temperature: Keep below 25°C, in the original packaging, protected from moisture and light.

Olopatadine may interact with other medications that influence histamine pathways or cause additive sedation.

Major Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): Increased risk of hypertensive reactions. - Tricyclic antidepressants: Potential for enhanced anticholinergic effects.

Moderate Interactions (Monitor Closely): - Other antihistamines: May increase sedation or dry‑mouth effects. - Sedative CNS depressants: Possible additive drowsiness. - Anticholinergic drugs: May exacerbate dry‑eye symptoms. - Beta‑blocker eye drops: Potential reduction in intra‑ocular pressure control. - Systemic corticosteroids: May alter ocular healing response.